Evidence map›Paper›PMID 34109728›Full record

ArticleJournal of cellular and molecular medicine2021

Otilonium Bromide treatment prevents nitrergic functional and morphological changes caused by chronic stress in the distal colon of a rat IBS model.

Chiara Traini, Eglantina Idrizaj, Rachele Garella, Maria-Simonetta Faussone-Pellegrini, Maria Caterina Baccari, Maria Giuliana Vannucchi

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Repurposing 1,4-Dihydropyridine Scaffold: 4-Imidazo[2,1-Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Nitric Oxide: From Gastric Motility to Gastric Dysmotility.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chiara TrainiResearch Unit of Histology and Embryology, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Eglantina IdrizajSection of Physiological Sciences, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Rachele GarellaSection of Physiological Sciences, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Maria-Simonetta Faussone-PellegriniResearch Unit of Histology and Embryology, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Maria Caterina BaccariSection of Physiological Sciences, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Maria Giuliana VannucchiResearch Unit of Histology and Embryology, Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID 0000-0002-1060-5025
University of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Irritable bowel syndrome (IBS) is a highly prevalent gastrointestinal disorder characterized by periods of remission and exacerbation. Among the risk factors to develop IBS, psychosocial stress is widely acknowledged. The water avoidance stress repeatedly applied (rWAS) is considered effective to study IBS etio-pathogenesis. Otilonium bromide (OB), a drug with multiple mechanisms of action, is largely used to treat IBS patients. Orally administered, it concentrates in the large bowel and significantly ameliorates the IBS symptomatology. Presently, we tested whether rWAS rats developed neuro-muscular abnormalities in the distal colon and whether OB treatment prevented them. The investigation was focussed on the nitrergic neurotransmission by combining functional and morphological methodologies. The results confirm rWAS as reliable animal model to investigate the cellular mechanisms responsible for IBS: exposure to one-hour psychosocial stress for 10 days depressed muscle contractility and increased iNOS expression in myenteric neurons. OB treatment counteracted these effects. We hypothesize that these effects are due to the corticotropin-releasing factor (CRF) release, the main mediator of the psychosocial stress, followed by a CRF1receptor activation. OB, that was shown to prevent CRF1r activation, reasonably interrupted the cascade events that bring to the mechanical and immunohistochemical changes affecting rWAS rat colon.

Indexed as

AnimalsColonCorticotropin-Releasing HormoneCRF Receptor, Type 1Gastrointestinal AgentsIrritable Bowel SyndromeMaleNitric OxideNitric Oxide Synthase Type IIQuaternary Ammonium CompoundsRatsRats, WistarReceptors, Corticotropin-Releasing HormoneStress, PsychologicalCorticotropin-Releasing HormoneCRF Receptor, Type 1Gastrointestinal AgentsNitric OxideNitric Oxide Synthase Type IIoctyloniumQuaternary Ammonium CompoundsReceptors, Corticotropin-Releasing Hormonecorticotropin-releasing factorfaecal pelletgiant contractionsinducible nitric oxide synthaseirritable bowel syndromeneuronal nitric oxide synthaseNG-nitro-L-arginineprotein gene product 9.5repeated water avoidance stresstetrodotoxin

Identifiers

PMID34109728
PMCPMC8278105
OpenAlexW3170882944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.